Bank of Montreal
DAWN

Bank of Montreal’s Day One Biopharmaceuticals DAWN Stock Holding History

Bank of Montreal’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37,895
Closed -$507K – 3882
2023
Q2 		$507K Buy
+37,895
New +$495K ﹤0.01% 2592

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Bank of Montreal's DAWN Position: Q3 2023 in Review

Bank of Montreal sold out of Day One Biopharmaceuticals (DAWN) in Q3 2023, closing a stake of 37,895 shares — an estimated $507K sold.

Bank of Montreal first reported a position in DAWN in Q2 2023 and held it in 1 quarter. The position peaked at $507K in Q2 2023. 130 funds tracked by Wall St. Rank hold DAWN as of Q3 2023.

  • Bank of Montreal reported no remaining Day One Biopharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 37,895 Day One Biopharmaceuticals shares in Q3 2023, an estimated $507K.
  • Bank of Montreal first reported a position in Day One Biopharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Bank of Montreal's Day One Biopharmaceuticals position peaked at $507K in Q2 2023.
  • 130 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.